Patent ID: 8618093

Claim:
A method of treating ocular hypertension which comprises administering to an eye a composition comprising about 0.5% (w/v) timolol or pharmaceutically acceptable salts thereof, and about 0.03% (w/v) of cyclopentane N-ethyl heptenamide-5-cis-2-(3-Î±-hydroxy-5-phenyl-1-trans-pentenyl)-3-,5-dihydroxy,[1Î±,2Î²,3Î±,5Î±] wherein said composition produces at least one reduced side effect relative to a second composition comprising the same amount of cyclopentane N-ethyl heptenamide-5-cis-2-(3-Î±-hydroxy-5-phenyl-1-trans-pentenyl)-3-,5-dihydroxy,[1Î±,2Î²,3Î±,5Î±] without said timolol.